GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » Gross Profit

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Gross Profit : ¥10,253 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co Gross Profit?

Joincare Pharmaceutical Group Industry Co's gross profit for the three months ended in Mar. 2024 was ¥2,751 Mil. Joincare Pharmaceutical Group Industry Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ¥10,253 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Joincare Pharmaceutical Group Industry Co's gross profit for the three months ended in Mar. 2024 was ¥2,751 Mil. Joincare Pharmaceutical Group Industry Co's Revenue for the three months ended in Mar. 2024 was ¥4,340 Mil. Therefore, Joincare Pharmaceutical Group Industry Co's Gross Margin % for the quarter that ended in Mar. 2024 was 63.39%.

Joincare Pharmaceutical Group Industry Co had a gross margin of 63.39% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Joincare Pharmaceutical Group Industry Co was 64.35%. The lowest was 59.07%. And the median was 62.61%.


Joincare Pharmaceutical Group Industry Co Gross Profit Historical Data

The historical data trend for Joincare Pharmaceutical Group Industry Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joincare Pharmaceutical Group Industry Co Gross Profit Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,709.44 8,647.42 10,187.39 10,890.49 10,347.89

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,845.58 2,600.74 2,368.35 2,533.22 2,751.20

Competitive Comparison of Joincare Pharmaceutical Group Industry Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's Gross Profit falls into.



Joincare Pharmaceutical Group Industry Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Joincare Pharmaceutical Group Industry Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=16646.35 - 6298.465
=10,348

Joincare Pharmaceutical Group Industry Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=4339.814 - 1588.615
=2,751

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥10,253 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Joincare Pharmaceutical Group Industry Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,751 / 4339.814
=63.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Joincare Pharmaceutical Group Industry Co  (SHSE:600380) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Joincare Pharmaceutical Group Industry Co had a gross margin of 63.39% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Joincare Pharmaceutical Group Industry Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines